Delaware Code
Subchapter II. Maximum Allowable Cost Pricing for Prescription Drugs and Reimbursement for and Provision of Pharmacy Goods or Services [For application of this subchapter, see 80 Del. Laws, c. 245, § 2; and 83 Del. Laws, c. 256, § 15]
§ 3321A. Definitions [For application of this section, see 80 Del. Laws, c. 245, § 2].

As used in this subchapter:

(1) “Claim” means a request from a pharmacy or pharmacist to be reimbursed for the cost of filling or refilling a prescription for a drug or for providing a medical supply or device.
(2) “Contracted pharmacy” means a pharmacy that participates in the network of a pharmacy benefits manager through a contract with a pharmacy benefits manager, a pharmacy services administration organization, or a group purchasing organization.
(3) “Drug shortage list” means a list of drug products listed on the federal Food and Drug Administration's Drug Shortages website.
(4) “Insurer” means any entity that provides health insurance coverage in this State as defined in § 903 of this title.
(5) “Maximum allowable cost” means the maximum amount that a pharmacy benefits manager will reimburse a pharmacist or pharmacy for the cost of a multi-sourced drug, medical product, or device.
(6) “Maximum allowable cost list” means the multi-source generic drugs, medical products, and devices for which a maximum allowable cost has been established by a pharmacy benefits manager or a purchaser.
(7) “Network providers” means those pharmacists and pharmacies who provide covered health-care services or supplies to an insured or a member pursuant to a contract with an insurer or pharmacy benefits manager.
(8) “Pharmacist” means as defined under § 2502 of Title 24.
(9) “Pharmacy” means as defined under § 2502 of Title 24.
(10) “Pharmacy benefits management services” means as defined under § 3351A of this title.
(11) “Pharmacy benefits manager” means as defined under § 3302A of this title.
(12) “Purchaser” means as defined under § 3351A of this title.